Treatment News : U.K. Throws Weight Behind Treatment as Prevention Model

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » January 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

January 24, 2013

U.K. Throws Weight Behind Treatment as Prevention Model

The U.K. Department of Health has published a position paper by England’s Expert Advisory Group on AIDS (EAGA) and the British HIV Association (BHIVA) on the use of antiretroviral therapy to prevent HIV transmission, calling vaginal transmission risk “extremely low” when the HIV-positive partner maintains an undetectable viral load and is free of sexually transmitted infections (STIs). The paper also asserts that successful ARV therapy is “as effective as consistent condom use in limiting viral transmission.”

Drawing upon studies such as the famed HPTN 052 trial that showed a 96 percent reduction in transmission risk when the HIV-positive partner of a serodiscordant heterosexual couple is taking effective HIV meds, EAGA and BHIVA recommend health care professionals discuss with their HIV-positive patients how proper ARV use may help prevent transmission. Their paper also encourages providers to discuss the potential for beginning therapy with those people living with the virus who wish to reduce their likelihood of transmitting to others.

The paper delineates three caveats that must be in place to ensure the best possible protection against transmission in heterosexual couples:

  • Neither partner must be infected with an STI (which can both make people more susceptible to becoming infected with HIV and which can raise viral loads in people living with the virus, making them more infectious).
  • The HIV-positive partner must have sustained an undetectable viral load for more than six months and have had an undetectable viral load on his or her last test.
  • Viral load tests should be conducted every three to four months.
While the authors of the paper acknowledge that there has been insufficient research to indicate whether ARVs protect similarly with sexual practices outside of vaginal sex, such as anal sex, they assert their expert opinion that the “extremely low risk” is likely similar when the above conditions are met.

“It must be noted that no single prevention method can completely prevent HIV transmission,” the paper states. “Antiretroviral therapy reduces the risk of transmission only of HIV. Irrespective of antiretroviral therapy, condoms remain the most effective way to prevent the spread of other sexually transmitted infections.”

The British groups’ pronouncement comes five years almost to the day after the Swiss Federal Commission for HIV/AIDS stated that heterosexual people with HIV cannot infect others if they are on successful ARVs, maintain an undetectable viral load and have no STIs. Many HIV advocates consider the BHIVA to be an especially cautious and conservative group, making its own bold statement about the matter all the more notable.

To read to position paper, click here.

Search: Expert Advisory Group on AIDS, EAGA, British HIV Association, BHIVA, transmission, treatment as prevention, antiretroviral therapy, ARV, sexually transmitted infections, undetectable viral load, serodiscordant couple, HPTN 052, Swiss Federal Commission for HIV/AIDS, U.K. Department of Health.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.